<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="marinedrugs-18-00228-t002" orientation="portrait" position="float">
 <object-id pub-id-type="pii">marinedrugs-18-00228-t002_Table 2</object-id>
 <label>Table 2</label>
 <caption>
  <p>Antithrombotic factors expressed in normal vascular endothelium and its functional mechanisms.</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Substance</th>
    <th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Function</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Antithrombotic Mechanism</th>
    <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> </th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TM</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Modulator of thrombin activity
     <break/>Anticoagulation and anti-inflammation factor
    </td>
    <td colspan="3" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">Suppression of coagulation via protein C activation
     <break/>Enhancement of fibrinolysis via TAFI activation 
     <break/>Inhibition of PAMPs/DAMPs and complement factors
    </td>
   </tr>
   <tr>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Heparan sulfate</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Activator of AT and TFPI </td>
    <td colspan="3" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">Suppression of coagulation via inhibition of thrombin, FXa, and FVIIa, </td>
   </tr>
   <tr>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TFPI</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibitor of TF, FXa, and FVIIa</td>
    <td colspan="3" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">Suppression of coagulation initiation via inhibition of TF, FXa and FVIIa</td>
   </tr>
   <tr>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Protein S</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Activator of APC and TFPI</td>
    <td colspan="3" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">Enhancement of APC-mediated anticoagulation and
     <break/>TFPI-mediated anticoagulation
    </td>
   </tr>
   <tr>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PGI
     <sub>2</sub>
    </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibitor of platelet activation</td>
    <td colspan="3" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">Inhibition of platelet activation</td>
   </tr>
   <tr>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ecto-ATP/ADPase</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibitor of platelet activation</td>
    <td colspan="3" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">Inhibition of platelet activation</td>
   </tr>
   <tr>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NO</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vasodilator</td>
    <td colspan="3" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">Inhibition of platelet activation and decrease of shear stress</td>
   </tr>
   <tr>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">t-PA</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Activator of fibrinolysis</td>
    <td colspan="3" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">Activation of plasminogen to plasmin </td>
   </tr>
   <tr>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IL-4</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-inflammatory cytokine</td>
    <td colspan="3" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">Inhibition of vascular endothelial inflammation</td>
   </tr>
   <tr>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IL-10</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-inflammatory cytokine</td>
    <td colspan="3" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">Inhibition of vascular endothelial inflammation</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn>
   <p>TM, thrombomodulin; APC, activated protein C; TAFI, thrombin-activated fibrinolysis inhibitor; PAMPs, pathogen-associated molecular patterns; DAMPs, damage-associated molecular patterns; AT, antithrombin; TFPI, tissue factor pathway inhibitor; NO, nitric oxide; PGI
    <sub>2</sub>, prostacyclin; t-PA, tissue plasminogen activator; IL-4, interleukin-4; IL-10, interleukin-10.
   </p>
  </fn>
 </table-wrap-foot>
</table-wrap>
